1. ABOUT THE DATASET
Title: Blood types and their relationship with COVID-19 among a study population in Iraq
Creator(s): Dhurgham Al-Fahad and Sakthivel Vaiyapuri    
Organisation(s): 
Department of Pathological Analysis, College of Science, University of Thi-Qar, Thi-Qar, Iraq
School of Pharmacy, University of Reading, UK 
Rights-holder(s): University of Reading and University of Thi-Qar, Iraq.  
Publication Year: 2020
Description: This dataset was developed using a range of different characteristic details from COVID-19 patients who were admitted at different hospitals in Iraq. The purpose of this study was to determine if there is any direct relationship between the blood types and susceptibility to contract COVID-19. We also used this data to analyse any links between the clinical symptoms and patientsŐ blood types.   
Cite as: Dhurgham Al-Fahad, and Sakthivel Vaiyapuri (2020): Blood types and their relationship with COVID-19 among a study population in Iraq. University of Reading. Dataset. http://dx.doi.org/10.17864/1947.278. 
Related publication: Khalid R. Majeed, Dhurgham Al-Fahad, Hayder H. Jalood, Haider A. Hantosh, Mrtatha K. Ali, Sumiktsal Sakthivel, Harry F. Williams, Jonathan M. Gibbins, Ketan Patel, M. Fazil Baksh, and Sakthivel Vaiyapuri, RhD blood type significantly influences the susceptibility to contract COVID-19 among a study population in Iraq, F1000 Research, 2020 Submitted). 
Contact: s.vaiyapuri@reading.ac.uk 

2. TERMS OF USE
Copyright 2020 University of Reading and University of Thi-Qar. This dataset is licensed under a Creative Commons Attribution 4.0 International Licence: https://creativecommons.org/licenses/by/4.0/.

3. PROJECT AND FUNDING INFORMATION
This dataset was not created in the course of a funded project.

4. CONTENTS
File listing
COVID-19_dataset.csv
This dataset was created using details collected at admission from patients in various hospitals in Iraq for COVID-19 treatment. 
Number of variables include gender, age, place of isolation, patient in date, patient out date, incubation period, blood group, control blood group, severity of disease, outcome of treatment, risk factors, infection type and clinical symptoms observed.  

Number of cases/rows: this dataset contains details from 5668 patients. 

5. METHODS
       We collected data such as the blood group, clinical symptoms at admission, pre-existing risk factors, age, gender and clinical outcomes (recovered/died) from 5,668 COVID-19 patients (the disease was confirmed by real-time polymerase chain reaction) who were admitted to Al-Hussein Teaching Hospital, Thi-Qar and Alkarama Teaching Hospital, Wasit in Iraq between March and June 2020. The blood type data from the same number of control (non-COVID-19) individuals was also collected from the same hospitals to determine the relationship between the blood types and COVID-19. The study design, data collection and consent forms were approved by the ethical committee at Thi-Qar Health Directorate, the Ministry of Health, Republic of Iraq, and all the data were anonymised prior to analysis.